Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.
Ann Thorac Surg
; 103(1): e9-e10, 2017 Jan.
Article
en En
| MEDLINE
| ID: mdl-28007287
ABSTRACT
Management of heparin-induced thrombocytopenia (HIT) entails cessation of heparin and initiation of a nonheparin parenteral anticoagulant such as danaparoid. Danaparoid cross-reactivity with HIT antibodies is an uncommon complication of treatment of HIT. We report the case of confirmed HIT and in vivo cross-reactivity with danaparoid, complicating severe sepsis due to an infectious endocarditis treated by cardiac surgery.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trombocitopenia
/
Heparina
/
Sulfatos de Condroitina
/
Dermatán Sulfato
/
Procedimientos Quirúrgicos Cardíacos
/
Enfermedades de las Válvulas Cardíacas
/
Heparitina Sulfato
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ann Thorac Surg
Año:
2017
Tipo del documento:
Article
País de afiliación:
Francia